Navigation Links
Two Studies Test Impact of Drugs to Slow Progression of Type 1 Diabetes
Date:6/27/2011

ROCKVILLE, Md., June 27, 2011 /PRNewswire-USNewswire/ -- Results of two studies testing drugs to slow or stop the immune system's attack on insulin-producing cells in people newly diagnosed with type 1 diabetes will be presented at the American Diabetes Association's (ADA) 71st Scientific Sessions in San Diego and simultaneously published online in the Lancet. The studies were conducted by the National Institutes of Health's international network of researchers, Type 1 Diabetes TrialNet Study Group, led by the National Institute of Diabetes and Digestive and Kidney Diseases.

Both TrialNet studies aimed to preserve secretion of insulin, the hormone that controls blood glucose levels; one with the drug abatacept, and the other with a vaccine called glutamic acid decarboxylase (GAD).  When type 1 diabetes is diagnosed, most patients retain a limited ability to make insulin, which is generally lost rapidly over the following one to two years. All study participants received intensive management of their diabetes during the trial, with a goal of keeping HbA1c levels within current ADA recommendations.

In the first study, abatacept (Orencia), an immune system modulator currently used to treat several inflammatory diseases, was evaluated in 112 people, ages 6 to 36, with newly diagnosed  type 1 diabetes. Participants were randomized to receive injections of either abatacept or placebo over two years. The group treated with abatacept had a 9.6 month delay in the progression of loss of insulin production.  After two years, a marker for the production of insulin was 59 percent higher in the participants treated with abatacept compared to the placebo group. Long-term retention of the ability to make even small amounts of insulin is associated with better glucose control and improved outcomes in diabetes.  

In the second study, GAD-alum, an antigen based therapy aiming to suppress the immune response, was tested in 14
'/>"/>

SOURCE TrialNet
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Studies Show Effect of BYDUREON™ on A1C and Weight for Up to Three Years
2. Pearl Therapeutics Advances Its Long-Acting Bronchodilator Combination Product Candidate into Four Additional Phase 2 Studies
3. Best of ASCO Features Two Studies Led by US Oncology Research Affiliated Physicians
4. Data from Clinical Studies of bioTheranostics CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting
5. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
6. Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting
7. Additional Data From Multiple Phase 1 and 2 Studies of S*BIOs Novel JAK2 Inhibitor SB1518 Demonstrate Safety and Efficacy for Treatment of Symptomatic Myelofibrosis (MF)
8. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
9. Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
10. Lilly Oncology to Unveil Data From More Than 30 Studies at ASCO
11. New Studies Support CardioFocus HeartLight™ Endoscopic Ablation Systems Notable Treatment Results for Paroxysmal Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... June 29, 2015  New guidelines released today ... Association give hope for better outcomes to the ... acute ischemic stroke each year. Stryker,s Trevo ® ... used in the clinical trials that provided data ... guidelines strongly recommend endovascular therapy with stent retrievers ...
(Date:6/29/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... public offering of units. Each unit will consist of ... purchase common stock and Series B warrants to purchase ... offering would result in them beneficially owning more than ...
(Date:6/29/2015)... June 29, 2015  Alimera Sciences, Inc. (NASDAQ: ... the research, development and commercialization of prescription ophthalmic pharmaceuticals, ... Officer and Chief Financial Officer, will present at the ... 2015 at 8:00 a.m. ET at Le Parker Meridien ... The presentation will be webcast live and will ...
Breaking Medicine Technology:New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3
... a Standard of Care, WASHINGTON, March 17 ... the Society of Interventional,Radiology,s 33rd Annual Scientific Meeting show ... up a blood clot in most patients,much quicker than ... guided,directly to the clot via a catheter in the ...
... on Outcomes of New Analyses or Confirmatory Trial, ... Tuesday March 18, 2008, BERKELEY HEIGHTS, N.J., ... announced that the Food and Drug,Administration,s (FDA) Center ... available data are not adequate to support approval ...
Cached Medicine Technology:New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 2New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 3New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 4New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 5FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 2FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 3FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 4FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 5FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 6
(Date:6/30/2015)... ... June 30, 2015 , ... The American Psychiatric Nurses ... Disney’s Coronado Springs Resort in Lake Buena Vista, Florida, and will offer more ... event for psychiatric-mental health nursing draws more than 1,500 health care professionals from ...
(Date:6/30/2015)... ... 30, 2015 , ... Medflow, the leader in the ophthalmic ... records system from the company exclusively dedicated to helping eye care professionals for ... state-of-the-art solution combining modern cloud technology with Medflow’s proven expertise in the eye ...
(Date:6/30/2015)... ... 2015 , ... Scott Purdy, the spokesperson for Dephinitive Systems LLC, announces today ... that the XO stands for eXtra Operability (XO) which was chosen to reflect the ... Revenue Cycle. , Provider XO, based in Cleveland OH, is part of the ...
(Date:6/29/2015)... ... June 30, 2015 , ... ... Richards as a 2015-2016 inductee into its VIP Woman of the Year ... is the nation’s leading networking organization exclusively for professional women, boasting more than ...
(Date:6/29/2015)... ... 2015 , ... Aespala Medspa and Plastic Surgery is proud to introduce the ... , Dr. Dreyfuss received his medical degree from Emory University in Atlanta before completing ... Surgery Fellowship at the University of Chicago. He has taught and practiced medicine in ...
Breaking Medicine News(10 mins):Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Medflow Launches MEDFLOW 2.0 EHR – The Cloud-Based Ophthalmology EHR 2Health News:Dephinitive Systems Is Getting a New Name 2Health News:National Association of Professional Women Inducts Melanie Richards, DMD, of Powdersville Pediatric Dentistry, Into its VIP Woman of the Year Circle 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 3
... from Matigara, Darjeeling District in West Bengal & Kuttanad in ... H7) as per report received from High Animal Security Disease ... reported from these two places. ,In Matigara, ... death of 2500 birds on 5-6th May, 2007. A team ...
... in a support group after diagnosis, use of support ... survivors receive referrals to such programs from their physicians, ... finds that cancer survivors are more likely to attend ... conditions, but there is little active support for such ...
... A leading expert in Germany has spawned a major ... tonnes of methane into the atmosphere every year ... Keppler of the Max Planck Institute for Chemistry has ... January 2006 that they had detected methane exhaled from ...
... women with a history of migraine and other headaches are ... the eye which can lead to severe vision problems ... to a study published in the May 15, 2007, issue ... Neurology. ,For the study, researchers reviewed the headache ...
... conducted to understand dietary patterns and chronic obstructive pulmonary ... halves the chances of developing progressive inflammatory lung disease ... an umbrella term for chronic progressive lung disease, such ... tracked the health of almost 43,000 men, who were ...
... infant mortality, cancer, accidental death, and diabetes than any other ... to a state health official, the Sioux Falls Argus Leader ... Department, at the request of the Zaniya Task Force, recently ... the state's population and found what he called "very somber ...
Cached Medicine News:Health News:Psychosocial Support for Cancer Survivors Needs Strengthening 2Health News:Scientists Saying Against Trees Sparks Debate 2Health News:Mid-Life Headaches May Increase Risk of Vision Problems 2Health News:American Indians in South Dakota Have More Health Problems Than Others in State, Nationwide, Health Official Says 2
Inquire...
... three styles. Each style has multiple sizes. ... popular style. Pectoral Implants are available non-sterile ... individually, not in pairs. Both styles are ... for a specific side and are directional. ...
... In vivo results may be affected by the ... scar tissue can impact the desired augment-ation 1 ... from patient to patient. Implant dimensions can be ... surgical scissors. All dimensions in centimeters. This device ...
... IQmark family elevates your ECG and Spirometry capabilities ... and efficient patient care. The IQmark Diagnostic PDA ... clinics and medical centers as well as for ... conjunction with the IQmark Digital ECG PDA and ...
Medicine Products: